Summary
Juno Therapeutics operates as a clinical-stage biotechnology company. The Company focuses on developing immunotherapies for cancer and other research services. Juno Therapeutics serves the healthcare sector in the United States.
Deals Overview
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Senior Management
Hans Bishop
President and CEO
Steven D. Harr
CFO
Howard H. Pien
Chairman